Gail J. Roboz
AuthID: R-00F-M9N
1
TITLE: An international phase 3 randomized, placebo-controlled study of CC-486 (oral azacitidine) maintenance therapy in patients with acute myeloid leukemia (AML) in complete remission (CR): The Quazar AML maintenance trial.
AUTHORS: Gail J Roboz; Farhad Ravandi; Dominik Selleslag; Pau Montesinos; Andrew Wei; Kimmo Porkka; Antonio Almeida; Michael R Savona; Sanjay Ram Mohan; Jose F Falantes; Maria Teresa Voso; Keshava Kumar; Frederic Camus; Ignazia La Torre; Hagop Kantarjian; Barry Skikne;
PUBLISHED: 2015, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 33, ISSUE: 15
AUTHORS: Gail J Roboz; Farhad Ravandi; Dominik Selleslag; Pau Montesinos; Andrew Wei; Kimmo Porkka; Antonio Almeida; Michael R Savona; Sanjay Ram Mohan; Jose F Falantes; Maria Teresa Voso; Keshava Kumar; Frederic Camus; Ignazia La Torre; Hagop Kantarjian; Barry Skikne;
PUBLISHED: 2015, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 33, ISSUE: 15
INDEXED IN: 
WOS
WOS